NineteenGale Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

NineteenGale Therapeutics General Information

Description

Provider of healthcare services based in Toronto, Ontario. The company specializes in identifying and developing novel cannabinoid-inspired drugs for bipolar disorder, anxiety, and pain management to help overcome the neurodegenerative disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Toronto, Ontario
  • Canada
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Toronto, Ontario
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NineteenGale Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NineteenGale Therapeutics‘s full profile, request access.

Request a free trial

NineteenGale Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NineteenGale Therapeutics‘s full profile, request access.

Request a free trial

NineteenGale Therapeutics FAQs

  • When was NineteenGale Therapeutics founded?

    NineteenGale Therapeutics was founded in 2020.

  • Where is NineteenGale Therapeutics headquartered?

    NineteenGale Therapeutics is headquartered in Toronto, Canada.

  • What industry is NineteenGale Therapeutics in?

    NineteenGale Therapeutics’s primary industry is Drug Discovery.

  • Is NineteenGale Therapeutics a private or public company?

    NineteenGale Therapeutics is a Private company.

  • What is NineteenGale Therapeutics’s current revenue?

    The current revenue for NineteenGale Therapeutics is .

  • Who are NineteenGale Therapeutics’s investors?

    Cyclica and NeuroTheryX have invested in NineteenGale Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process